Global Non-alcoholic Steatohepatitis Market Research Report 2025(Status and Outlook)

March 2025 | 227 pages | ID: G69EB0800D4FEN
Bosson Research

Abstracts

Report Overview

Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver.

This report provides a deep insight into the global Non-alcoholic Steatohepatitis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-alcoholic Steatohepatitis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-alcoholic Steatohepatitis market in any manner.

Global Non-alcoholic Steatohepatitis Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AstraZeneca

Pfizer

GSK

Novo Nordisk

Roche

AbbVie

Galectin Therapeutics

Galmed Pharmaceuticals

Gilead

Intercept pharma

Non-alcoholic Steatohepatitis

Takeda

Market Segmentation (by Type)

Solid

Liquid

Market Segmentation (by Application)

Oral

Parenteral

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Non-alcoholic Steatohepatitis Market
• Overview of the regional outlook of the Non-alcoholic Steatohepatitis Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-alcoholic Steatohepatitis Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Non-alcoholic Steatohepatitis
1.2 Key Market Segments
  1.2.1 Non-alcoholic Steatohepatitis Segment by Type
  1.2.2 Non-alcoholic Steatohepatitis Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Non-alcoholic Steatohepatitis Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Non-alcoholic Steatohepatitis Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Non-alcoholic Steatohepatitis Product Life Cycle
3.3 Global Non-alcoholic Steatohepatitis Sales by Manufacturers (2020-2025)
3.4 Global Non-alcoholic Steatohepatitis Revenue Market Share by Manufacturers (2020-2025)
3.5 Non-alcoholic Steatohepatitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Non-alcoholic Steatohepatitis Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Non-alcoholic Steatohepatitis Manufacturing Sites, Area Served, Product Type
3.8 Non-alcoholic Steatohepatitis Market Competitive Situation and Trends
  3.8.1 Non-alcoholic Steatohepatitis Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Non-alcoholic Steatohepatitis Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 NON-ALCOHOLIC STEATOHEPATITIS INDUSTRY CHAIN ANALYSIS

4.1 Non-alcoholic Steatohepatitis Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF NON-ALCOHOLIC STEATOHEPATITIS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Non-alcoholic Steatohepatitis Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Non-alcoholic Steatohepatitis Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS MARKET SALES BY REGION

6.1 Global Non-alcoholic Steatohepatitis Sales by Region
  6.1.1 Global Non-alcoholic Steatohepatitis Sales by Region
  6.1.2 Global Non-alcoholic Steatohepatitis Sales Market Share by Region
6.2 Global Non-alcoholic Steatohepatitis Market Size by Region
  6.2.1 Global Non-alcoholic Steatohepatitis Market Size by Region
  6.2.2 Global Non-alcoholic Steatohepatitis Market Size Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Non-alcoholic Steatohepatitis Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Non-alcoholic Steatohepatitis Market Size by Type
7.3 North America Non-alcoholic Steatohepatitis Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Non-alcoholic Steatohepatitis Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Non-alcoholic Steatohepatitis Market Size by Type
8.3 Europe Non-alcoholic Steatohepatitis Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Type
9.3 Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Non-alcoholic Steatohepatitis Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Non-alcoholic Steatohepatitis Market Size by Type
10.3 South America Non-alcoholic Steatohepatitis Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Non-alcoholic Steatohepatitis Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Non-alcoholic Steatohepatitis Market Size by Type
11.3 Middle East and Africa Non-alcoholic Steatohepatitis Market Size by Application

12 NON-ALCOHOLIC STEATOHEPATITIS MARKET PRODUCTION BY REGION

12.1 Global Production of Non-alcoholic Steatohepatitis by Region(2020-2025)
12.2 Global Non-alcoholic Steatohepatitis Revenue Market Share by Region (2020-2025)
12.3 Global Non-alcoholic Steatohepatitis Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Non-alcoholic Steatohepatitis Production
  12.4.1 North America Non-alcoholic Steatohepatitis Production Growth Rate (2020-2025)
  12.4.2 North America Non-alcoholic Steatohepatitis Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Non-alcoholic Steatohepatitis Production
  12.5.1 Europe Non-alcoholic Steatohepatitis Production Growth Rate (2020-2025)
  12.5.2 Europe Non-alcoholic Steatohepatitis Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Non-alcoholic Steatohepatitis Production (2020-2025)
  12.6.1 Japan Non-alcoholic Steatohepatitis Production Growth Rate (2020-2025)
  12.6.2 Japan Non-alcoholic Steatohepatitis Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Non-alcoholic Steatohepatitis Production (2020-2025)
  12.7.1 China Non-alcoholic Steatohepatitis Production Growth Rate (2020-2025)
  12.7.2 China Non-alcoholic Steatohepatitis Production, Revenue, Price and Gross Margin (2020-2025)

13 NON-ALCOHOLIC STEATOHEPATITIS MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Non-alcoholic Steatohepatitis Sales Market Share by Type (2020-2033)
13.3 Global Non-alcoholic Steatohepatitis Market Size Market Share by Type (2020-2033)
13.4 Global Non-alcoholic Steatohepatitis Price by Type (2020-2033)

14 NON-ALCOHOLIC STEATOHEPATITIS MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Non-alcoholic Steatohepatitis Market Sales by Application (2020-2033)
14.3 Global Non-alcoholic Steatohepatitis Market Size (M USD) by Application (2020-2033)
14.4 Global Non-alcoholic Steatohepatitis Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 AstraZeneca
  15.1.1 AstraZeneca Basic Information
  15.1.2 AstraZeneca Non-alcoholic Steatohepatitis Product Overview
  15.1.3 AstraZeneca Non-alcoholic Steatohepatitis Product Market Performance
  15.1.4 AstraZeneca Business Overview
  15.1.5 AstraZeneca SWOT Analysis
  15.1.6 AstraZeneca Recent Developments
15.2 Pfizer
  15.2.1 Pfizer Basic Information
  15.2.2 Pfizer Non-alcoholic Steatohepatitis Product Overview
  15.2.3 Pfizer Non-alcoholic Steatohepatitis Product Market Performance
  15.2.4 Pfizer Business Overview
  15.2.5 Pfizer SWOT Analysis
  15.2.6 Pfizer Recent Developments
15.3 GSK
  15.3.1 GSK Basic Information
  15.3.2 GSK Non-alcoholic Steatohepatitis Product Overview
  15.3.3 GSK Non-alcoholic Steatohepatitis Product Market Performance
  15.3.4 GSK Business Overview
  15.3.5 GSK SWOT Analysis
  15.3.6 GSK Recent Developments
15.4 Novo Nordisk
  15.4.1 Novo Nordisk Basic Information
  15.4.2 Novo Nordisk Non-alcoholic Steatohepatitis Product Overview
  15.4.3 Novo Nordisk Non-alcoholic Steatohepatitis Product Market Performance
  15.4.4 Novo Nordisk Business Overview
  15.4.5 Novo Nordisk Recent Developments
15.5 Roche
  15.5.1 Roche Basic Information
  15.5.2 Roche Non-alcoholic Steatohepatitis Product Overview
  15.5.3 Roche Non-alcoholic Steatohepatitis Product Market Performance
  15.5.4 Roche Business Overview
  15.5.5 Roche Recent Developments
15.6 AbbVie
  15.6.1 AbbVie Basic Information
  15.6.2 AbbVie Non-alcoholic Steatohepatitis Product Overview
  15.6.3 AbbVie Non-alcoholic Steatohepatitis Product Market Performance
  15.6.4 AbbVie Business Overview
  15.6.5 AbbVie Recent Developments
15.7 Galectin Therapeutics
  15.7.1 Galectin Therapeutics Basic Information
  15.7.2 Galectin Therapeutics Non-alcoholic Steatohepatitis Product Overview
  15.7.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Product Market Performance
  15.7.4 Galectin Therapeutics Business Overview
  15.7.5 Galectin Therapeutics Recent Developments
15.8 Galmed Pharmaceuticals
  15.8.1 Galmed Pharmaceuticals Basic Information
  15.8.2 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product Overview
  15.8.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product Market Performance
  15.8.4 Galmed Pharmaceuticals Business Overview
  15.8.5 Galmed Pharmaceuticals Recent Developments
15.9 Gilead
  15.9.1 Gilead Basic Information
  15.9.2 Gilead Non-alcoholic Steatohepatitis Product Overview
  15.9.3 Gilead Non-alcoholic Steatohepatitis Product Market Performance
  15.9.4 Gilead Business Overview
  15.9.5 Gilead Recent Developments
15.10 Intercept pharma
  15.10.1 Intercept pharma Basic Information
  15.10.2 Intercept pharma Non-alcoholic Steatohepatitis Product Overview
  15.10.3 Intercept pharma Non-alcoholic Steatohepatitis Product Market Performance
  15.10.4 Intercept pharma Business Overview
  15.10.5 Intercept pharma Recent Developments
15.11 Non-alcoholic Steatohepatitis
  15.11.1 Non-alcoholic Steatohepatitis Basic Information
  15.11.2 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product Overview
  15.11.3 Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product Market Performance
  15.11.4 Non-alcoholic Steatohepatitis Business Overview
  15.11.5 Non-alcoholic Steatohepatitis Recent Developments
15.12 Takeda
  15.12.1 Takeda Basic Information
  15.12.2 Takeda Non-alcoholic Steatohepatitis Product Overview
  15.12.3 Takeda Non-alcoholic Steatohepatitis Product Market Performance
  15.12.4 Takeda Business Overview
  15.12.5 Takeda Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-alcoholic Steatohepatitis Market Size Comparison by Region (M USD)
Table 5. Global Non-alcoholic Steatohepatitis Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Non-alcoholic Steatohepatitis Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Non-alcoholic Steatohepatitis Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Non-alcoholic Steatohepatitis Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-alcoholic Steatohepatitis as of 2024)
Table 10. Global Market Non-alcoholic Steatohepatitis Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Non-alcoholic Steatohepatitis Manufacturing Sites and Area Served
Table 12. Manufacturers Non-alcoholic Steatohepatitis Product Type
Table 13. Global Non-alcoholic Steatohepatitis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Non-alcoholic Steatohepatitis Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Non-alcoholic Steatohepatitis Sales by Region (2020-2025) & (K Units)
Table 25. Global Non-alcoholic Steatohepatitis Sales Market Share by Region (2020-2025)
Table 26. Global Non-alcoholic Steatohepatitis Market Size by Region (2020-2025) & (M USD)
Table 27. Global Non-alcoholic Steatohepatitis Market Size Market Share by Region (2020-2025)
Table 28. North America Non-alcoholic Steatohepatitis Market Size by Country (2020-2033) & (M USD)
Table 29. North America Non-alcoholic Steatohepatitis Sales by Country (2020-2033) & (K Units)
Table 30. North America Non-alcoholic Steatohepatitis Sales by Type (K Units)
Table 31. North America Non-alcoholic Steatohepatitis Market Size by Type (M USD)
Table 32. North America Non-alcoholic Steatohepatitis Sales (K Units) by Type (2020-2033)
Table 33. North America Non-alcoholic Steatohepatitis Market Size (M USD) by Type (2020-2033)
Table 34. North America Non-alcoholic Steatohepatitis Sales by Application (K Units)
Table 35. North America Non-alcoholic Steatohepatitis Market Size by Application (M USD)
Table 36. North America Non-alcoholic Steatohepatitis Sales (K Units) by Application (2020-2033)
Table 37. North America Non-alcoholic Steatohepatitis Market Size (M USD) by Application (2020-2033)
Table 38. Europe Non-alcoholic Steatohepatitis Market Size by Country (2020-2033) & (M USD)
Table 39. Europe Non-alcoholic Steatohepatitis Sales by Country (2020-2033) & (K Units)
Table 40. Europe Non-alcoholic Steatohepatitis Sales by Type (K Units)
Table 41. Europe Non-alcoholic Steatohepatitis Market Size by Type (M USD)
Table 42. Europe Non-alcoholic Steatohepatitis Sales (K Units) by Type (2020-2033)
Table 43. Europe Non-alcoholic Steatohepatitis Market Size (M USD) by Type (2020-2033)
Table 44. Europe Non-alcoholic Steatohepatitis Sales by Application (K Units)
Table 45. Europe Non-alcoholic Steatohepatitis Market Size by Application (M USD)
Table 46. Europe Non-alcoholic Steatohepatitis Sales (K Units) by Application (2020-2033)
Table 47. Europe Non-alcoholic Steatohepatitis Market Size (M USD) by Application (2020-2033)
Table 48. Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Country (2020-2025) & (M USD)
Table 49. Asia-Pacific Non-alcoholic Steatohepatitis Sales by Country (2020-2025) & (K Units)
Table 50. Asia-Pacific Non-alcoholic Steatohepatitis Sales by Type (K Units)
Table 51. Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Type (M USD)
Table 52. Asia-Pacific Non-alcoholic Steatohepatitis Sales (K Units) by Type (2020-2033)
Table 53. Asia-Pacific Non-alcoholic Steatohepatitis Market Size (M USD) by Type (2020-2025)
Table 54. Asia-Pacific Non-alcoholic Steatohepatitis Sales by Application (K Units)
Table 55. Asia-Pacific Non-alcoholic Steatohepatitis Market Size by Application (M USD)
Table 56. Asia-Pacific Non-alcoholic Steatohepatitis Sales (K Units) by Application (2020-2033)
Table 57. Asia-Pacific Non-alcoholic Steatohepatitis Market Size (M USD) by Application (2020-2025)
Table 58. South America Non-alcoholic Steatohepatitis Market Size by Country (2020-2033) & (M USD)
Table 59. South America Non-alcoholic Steatohepatitis Sales by Country (2020-2033) & (K Units)
Table 60. South America Non-alcoholic Steatohepatitis Sales by Type (K Units)
Table 61. South America Non-alcoholic Steatohepatitis Market Size by Type (M USD)
Table 62. South America Non-alcoholic Steatohepatitis Sales (K Units) by Type (2020-2033)
Table 63. South America Non-alcoholic Steatohepatitis Market Size (M USD) by Type (2020-2033)
Table 64. South America Non-alcoholic Steatohepatitis Sales by Application (K Units)
Table 65. South America Non-alcoholic Steatohepatitis Market Size by Application (M USD)
Table 66. South America Non-alcoholic Steatohepatitis Sales (K Units) by Application (2020-2033)
Table 67. South America Non-alcoholic Steatohepatitis Market Size (M USD) by Application (2020-2033)
Table 68. Middle East and Africa Non-alcoholic Steatohepatitis Market Size by Country (2020-2033) & (M USD)
Table 69. Middle East and Africa Non-alcoholic Steatohepatitis Sales by Country (2020-2033) & (K Units)
Table 70. Middle East and Africa Non-alcoholic Steatohepatitis Sales by Type (K Units)
Table 71. Middle East and Africa Non-alcoholic Steatohepatitis Market Size by Type (M USD)
Table 72. Middle East and Africa Non-alcoholic Steatohepatitis Sales (K Units) by Type (2020-2033)
Table 73. Middle East and Africa Non-alcoholic Steatohepatitis Market Size (M USD) by Type (2020-2033)
Table 74. Middle East and Africa Non-alcoholic Steatohepatitis Sales by Application (K Units)
Table 75. Middle East and Africa Non-alcoholic Steatohepatitis Market Size by Application (M USD)
Table 76. Middle East and Africa Non-alcoholic Steatohepatitis Sales (K Units) by Application (2020-2033)
Table 77. Middle East and Africa Non-alcoholic Steatohepatitis Market Size (M USD) by Application (2020-2033)
Table 78. Global Non-alcoholic Steatohepatitis Production (K Units) by Region(2020-2025)
Table 79. Global Non-alcoholic Steatohepatitis Revenue (US$ Million) by Region (2020-2025)
Table 80. Global Non-alcoholic Steatohepatitis Revenue Market Share by Region (2020-2025)
Table 81. Global Non-alcoholic Steatohepatitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. North America Non-alcoholic Steatohepatitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Europe Non-alcoholic Steatohepatitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Japan Non-alcoholic Steatohepatitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. China Non-alcoholic Steatohepatitis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Global Non-alcoholic Steatohepatitis Sales by Type (K Units)
Table 87. Global Non-alcoholic Steatohepatitis Market Size by Type (M USD)
Table 88. Global Non-alcoholic Steatohepatitis Sales (K Units) by Type (2020-2033)
Table 89. Global Non-alcoholic Steatohepatitis Sales Market Share by Type (2020-2033)
Table 90. Global Non-alcoholic Steatohepatitis Market Size (M USD) by Type (2020-2033)
Table 91. Global Non-alcoholic Steatohepatitis Market Size Share by Type (2020-2033)
Table 92. Global Non-alcoholic Steatohepatitis Sales (K Units) by Application
Table 93. Global Non-alcoholic Steatohepatitis Market Size by Application(M USD)
Table 94. Global Non-alcoholic Steatohepatitis Sales by Application (2020-2033) & (K Units)
Table 95. Global Non-alcoholic Steatohepatitis Sales Market Share by Application (2020-2033)
Table 96. Global Non-alcoholic Steatohepatitis Market Size by Application (2020-2033) & (M USD)
Table 97. Global Non-alcoholic Steatohepatitis Market Share by Application (2020-2033)
Table 98. Global Non-alcoholic Steatohepatitis Sales Growth Rate by Application (2020-2033)
Table 99. AstraZeneca Basic Information
Table 100. AstraZeneca Non-alcoholic Steatohepatitis Product Overview
Table 101. AstraZeneca Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca SWOT Analysis
Table 104. AstraZeneca Recent Developments
Table 105. Pfizer Basic Information
Table 106. Pfizer Non-alcoholic Steatohepatitis Product Overview
Table 107. Pfizer Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Pfizer Business Overview
Table 109. Pfizer SWOT Analysis
Table 110. Pfizer Recent Developments
Table 111. GSK Basic Information
Table 112. GSK Non-alcoholic Steatohepatitis Product Overview
Table 113. GSK Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. GSK Business Overview
Table 115. GSK SWOT Analysis
Table 116. GSK Recent Developments
Table 117. Novo Nordisk Basic Information
Table 118. Novo Nordisk Non-alcoholic Steatohepatitis Product Overview
Table 119. Novo Nordisk Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Novo Nordisk Business Overview
Table 121. Novo Nordisk Recent Developments
Table 122. Roche Basic Information
Table 123. Roche Non-alcoholic Steatohepatitis Product Overview
Table 124. Roche Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Roche Business Overview
Table 126. Roche Recent Developments
Table 127. AbbVie Basic Information
Table 128. AbbVie Non-alcoholic Steatohepatitis Product Overview
Table 129. AbbVie Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. AbbVie Business Overview
Table 131. AbbVie Recent Developments
Table 132. Galectin Therapeutics Basic Information
Table 133. Galectin Therapeutics Non-alcoholic Steatohepatitis Product Overview
Table 134. Galectin Therapeutics Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Galectin Therapeutics Business Overview
Table 136. Galectin Therapeutics Recent Developments
Table 137. Galmed Pharmaceuticals Basic Information
Table 138. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product Overview
Table 139. Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Galmed Pharmaceuticals Business Overview
Table 141. Galmed Pharmaceuticals Recent Developments
Table 142. Gilead Basic Information
Table 143. Gilead Non-alcoholic Steatohepatitis Product Overview
Table 144. Gilead Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Gilead Business Overview
Table 146. Gilead Recent Developments
Table 147. Intercept pharma Basic Information
Table 148. Intercept pharma Non-alcoholic Steatohepatitis Product Overview
Table 149. Intercept pharma Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. Intercept pharma Business Overview
Table 151. Intercept pharma Recent Developments
Table 152. Non-alcoholic Steatohepatitis Basic Information
Table 153. Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Product Overview
Table 154. Non-alcoholic Steatohepatitis Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Non-alcoholic Steatohepatitis Business Overview
Table 156. Non-alcoholic Steatohepatitis Recent Developments
Table 157. Takeda Basic Information
Table 158. Takeda Non-alcoholic Steatohepatitis Product Overview
Table 159. Takeda Non-alcoholic Steatohepatitis Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 160. Takeda Business Overview
Table 161. Takeda Recent Developments
List of Figures
Figure 1. Product Picture of Non-alcoholic Steatohepatitis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-alcoholic Steatohepatitis Market Size (M USD), 2024-2033
Figure 5. Global Non-alcoholic Steatohepatitis Market Size (M USD) (2020-2033)
Figure 6. Global Non-alcoholic Steatohepatitis Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-alcoholic Steatohepatitis Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Non-alcoholic Steatohepatitis Product Life Cycle
Figure 13. Non-alcoholic Steatohepatitis Sales Share by Manufacturers in 2024
Figure 14. Global Non-alcoholic Steatohepatitis Revenue Share by Manufacturers in 2024
Figure 15. Non-alcoholic Steatohepatitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Non-alcoholic Steatohepatitis Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Non-alcoholic Steatohepatitis Revenue in 2024
Figure 18. Industry Chain Map of Non-alcoholic Steatohepatitis
Figure 19. Global Non-alcoholic Steatohepatitis Market PEST Analysis
Figure 20. Global Non-alcoholic Steatohepatitis Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Global Non-alcoholic Steatohepatitis Sales Market Share by Region (2020-2025)
Figure 26. Global Non-alcoholic Steatohepatitis Market Size Market Share by Region (2020-2025)
Figure 27. North American Market Snapshot
Figure 28. North America Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 29. North America Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. North America Non-alcoholic Steatohepatitis Market Size (M USD) by Country
Figure 31. USA Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 32. USA Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. Canada Non-alcoholic Steatohepatitis Sales (K Units) and Growth Rate (2020-2033)
Figure 34. Canada Non-alcoholic Steatohepatitis Market Size (M USD) and Growth Rate (2020-2033)
Figure 35. Mexico Non-alcoholic Steatohepatitis Sales (Units) and Growth Rate (2020-2033)
Figure 36. Mexico Non-alcoholic Steatohepatitis Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. North America Non-alcoholic Steatohepatitis Market Size (M USD)by Type
Figure 38. North America Non-alcoholic Steatohepatitis Market Size (M USD) by Application
Figure 39. Europe Market Snapshot
Figure 40. Europe Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 41. Europe Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 42. Europe Non-alcoholic Steatohepatitis Market Size (M USD) by Country
Figure 43. Germany Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 44. Germany Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 45. France Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. France Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. U.K. Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. U.K. Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 49. Italy Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. Italy Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 51. Spain Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Spain Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Europe Non-alcoholic Steatohepatitis Market Size (M USD) by Type
Figure 54. Europe Non-alcoholic Steatohepatitis Market Size (M USD) by Application
Figure 55. Asia-Pacific Market Snapshot
Figure 56. Asia-Pacific Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 57. Asia-Pacific Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Asia-Pacific Non-alcoholic Steatohepatitis Market Size (M USD) by Country
Figure 59. China Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. China Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Japan Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Japan Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. South Korea Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. South Korea Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. India Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. India Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. Southeast Asia Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. Southeast Asia Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Asia-Pacific Non-alcoholic Steatohepatitis Market Size (M USD) by Type
Figure 70. Asia-Pacific Non-alcoholic Steatohepatitis Market Size (M USD) by Application
Figure 71. South America Market Snapshot
Figure 72. South America Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 73. South America Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 74. South America Non-alcoholic Steatohepatitis Market Size (M USD) by Country
Figure 75. Brazil Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 76. Brazil Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 77. Argentina Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Argentina Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Columbia Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Columbia Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. South America Non-alcoholic Steatohepatitis Market Size (M USD) by Type
Figure 82. South America Non-alcoholic Steatohepatitis Market Size (M USD) by Application
Figure 83. Middle East and Africa Market Snapshot
Figure 84. Middle East and Africa Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 85. Middle East and Africa Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 86. Middle East and Africa Non-alcoholic Steatohepatitis Market Size (M USD) by Country
Figure 87. Saudi Arabia Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 88. Saudi Arabia Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 89. UAE Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. UAE Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. Egypt Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. Egypt Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Nigeria Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Nigeria Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. South Africa Non-alcoholic Steatohepatitis Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. South Africa Non-alcoholic Steatohepatitis Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. Middle East and Africa Non-alcoholic Steatohepatitis Market Size (M USD) by Type
Figure 98. Middle East and Africa Non-alcoholic Steatohepatitis Market Size (M USD) by Application
Figure 99. Global Non-alcoholic Steatohepatitis Production Market Share by Region (2020-2025)
Figure 100. North America Non-alcoholic Steatohepatitis Production (K Units) Growth Rate (2020-2025)
Figure 101. Europe Non-alcoholic Steatohepatitis Production (K Units) Growth Rate (2020-2025)
Figure 102. Japan Non-alcoholic Steatohepatitis Production (K Units) Growth Rate (2020-2025)
Figure 103. China Non-alcoholic Steatohepatitis Production (K Units) Growth Rate (2020-2025)
Figure 104. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 105. Global Non-alcoholic Steatohepatitis Market Size by Type (M USD)
Figure 106. Sales Market Share of Non-alcoholic Steatohepatitis by Type (2020-2033)
Figure 107. Sales Market Share of Non-alcoholic Steatohepatitis by Type in 2024
Figure 108. Market Size Share of Non-alcoholic Steatohepatitis by Type (2020-2033)
Figure 109. Market Size Share of Non-alcoholic Steatohepatitis by Type in 2024
Figure 110. Global Non-alcoholic Steatohepatitis Price (USD/Unit) by Type (2020-2033)
Figure 111. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 112. Global Non-alcoholic Steatohepatitis Market Size by Application(M USD)
Figure 113. Global Non-alcoholic Steatohepatitis Market Share by Application
Figure 114. Global Non-alcoholic Steatohepatitis Sales Market Share by Application (2020-2033)
Figure 115. Global Non-alcoholic Steatohepatitis Sales Market Share by Application in 2024
Figure 116. Global Non-alcoholic Steatohepatitis Market Share by Application (2020-2033)
Figure 117. Global Non-alcoholic Steatohepatitis Market Share by Application in 2024
Figure 118. Global Non-alcoholic Steatohepatitis Sales Growth Rate by Application (2020-2033)